Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-02-17

Clinical Trial Update: Ezetimibe Plus Atorvastatin Versus Atorvastatin in Untreated Subjects With Primary Hypercholesterolemia and Coronary Heart Disease (P03396) [Phase 3]

View source ↗

Summary

Phase 3 trial comparing ezetimibe plus atorvastatin versus atorvastatin alone in untreated primary hypercholesterolemia with coronary heart disease; study compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • atorvastatin (atorvastatin)
  • ezetimibe plus atorvastatin

Snippet

Sponsor: Organon and Co | Conditions: Hypercholesterolemia, Atherosclerosis | Phase 3 | Status: COMPLETED